Religare Enterprises working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
4.40×4.40×8.19×12.31×15.84×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.66×0.66×0.71×0.71×0.58×
24.88×24.88×8.57×4.32×0.48×
13.42×13.42×5.24×4.71×3.23×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RELIGARE₹216.14

Religare Enterprises Ltd.

· Banking & Finance
₹ CrorePeersSTARHEALTHPSBPRUDENTSHAREINDIASOUTHBANKSTYLMAHSCOOTERTMBMcap ₹7,173 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Receivable Days (DSO)15.8412.318.194.404.40
Asset Turnover0.580.710.710.660.66
Cash Conversion (CFO/Net Income)0.484.328.5724.8824.88
CFO/EBITDA3.234.715.2413.4213.42
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.